Tildren Injection

TILDREN Injection
Bone-Modifying Therapy for Horses

Composition and Administration

• Active ingredient: Tiludronic acid 50 mg/vial

• Equivalent to 56.91 mg disodium tiludronate

• Form: Powder and solvent for IV injection

• Solvent: Water for injection

Pharmacological Action

• Inhibits osteoclast activity effectively

• Reduces bone resorption without harm

• Maintains normal bone mineralization

• Preserves bone formation processes

Clinical Benefits

• Regulates excessive bone remodeling

• Treats lameness from bone diseases

• Effective for Navicular Disease cases

• Reduces symptoms of Bone Spavin

• Enables return to athletic activity

Additional Therapeutic Value

• May relieve vertebral-related back pain

• Promotes improved spinal flexibility

• Prevents bone loss during inactivity

• Maintains bone density in downtime

• Shows anti-arthritic potential in models

Indications for Use

• For lameness due to bone degeneration

• Targets osteolytic conditions in horses

• Enhances comfort and mobility performance

• Improves quality of equine athletic life

Please refer to the product label or consult with your veterinarian for specific dosing recommendations.

Tiludronic acid 50 mg/vial (as disodium tiludronate 56.91 mg/vial) Powder and solvent for intravenous injection. Solvent is water for injection